Skip to Main Content

Researchers at the Centers for Disease Control and Prevention released data Friday indicating that the newer two-strain Covid booster shots provide substantial protection against illness and hospitalization, even in the previously vaccinated.

The Food and Drug Administration said Friday that it will convene an advisory hearing next month to discuss what vaccines should look like going forward, including whether people who have never received any Covid vaccines should receive the bivalent as their first.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment